Morgan Stanley (NYSE: MS) affiliate files to sell 4,040 common shares under Rule 144
Rhea-AI Filing Summary
An affiliate associated with Morgan Stanley (MS) filed a notice to sell common stock under Rule 144. The planned transaction covers up to 4,040 shares of common stock, with an aggregate market value of $869,044.40, to be sold for cash on or after July 20, 2026 on the NYSE. The filing also lists a prior sale during the past three months of 2,775 shares of common stock on April 20, 2026 for total proceeds of $531,204.38.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 4,040 shares
Aggregate market value of planned sale: $869,044.40
Past 3-month shares sold: 2,775 shares
+2 more
5 metrics
Planned shares to be sold
4,040 shares
Maximum number of common shares covered by the Rule 144 notice
Aggregate market value of planned sale
$869,044.40
Aggregate market value of 4,040 common shares to be sold
Past 3-month shares sold
2,775 shares
Common shares sold on April 20, 2026 during the past three months
Value of past 3-month sale
$531,204.38
Total proceeds from 2,775 common shares sold on April 20, 2026
Proposed sale date
July 20, 2026
Date on or after which the 4,040 shares may be sold on the NYSE
Key Terms
Securities To Be Sold, Securities Sold During The Past 3 Months
2 terms
Securities To Be Sold regulatory
"144: Securities To Be Sold"
Securities Sold During The Past 3 Months regulatory
"144: Securities Sold During The Past 3 Months"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Form 144 filed for MS indicate about upcoming stock sales?
The Form 144 indicates a plan to sell up to 4,040 shares of common stock, with an aggregate market value of $869,044.40, for cash on or after July 20, 2026 on the NYSE.
Who is involved in handling the MS stock sales mentioned in the Form 144?
The notice references Morgan Stanley & Co. LLC and Morgan Stanley Smith Barney LLC, both located at 1585 Broadway, New York, NY 10036, in connection with the Rule 144 stock sale activity.